| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 9 |
| 1 | PREDNISOLONE ORAL | 9 |
| 2 | PREDNISOLONE ORAL SOLUTION | 9 |
| 3 | MYCOPHENOLATE MOFETIL | 8 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 8 |
| 5 | TACROLIMUS | 8 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 8 |
| 7 | TACROLIMUS OINTMENT 0.1% | 8 |
| 8 | METHYLPREDNISOLONE | 7 |
| 9 | ALBUTEROL SULFATE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 2 | 0.0007 |
| 1 | NIRSEVIMAB | 1 | 0.0006 |
| 2 | ZANAMIVIR | 1 | 0.0004 |
| 3 | LEMBOREXANT | 1 | 0.0003 |
| 4 | GALSULFASE | 1 | 0.0003 |
| 5 | BASILIXIMAB | 3 | 0.0003 |
| 6 | BECLOMETHASONE DIPROPIONATE | 1 | 0.0002 |
| 7 | ALEMTUZUMAB | 3 | 0.0002 |
| 8 | ACETYLCYSTEINE | 1 | 0.0001 |
| 9 | DASPONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] | 1 | 0.0006 |
| 2 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 4 | Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] | 2 | 0.0001 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 6 | Sulfone [EPC] | 1 | 0.0001 |
| 7 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 8 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |